CTSI Appoints John Routes, MD Co-Director

CTSI Appoints John Routes, MD Co-Director

John M. Routes, MD

John (Jack) M. Routes, MD

John Routes, MD, Professor of Pediatrics (Allergy and Immunology), has been appointed Co-Director of the Clinical and Translational Science Institute of Southeast Wisconsin (CTSI) by Reza Shaker, MD, Senior Associate Dean for Clinical and Translational Research and the Joseph E. Geenen Professor in Gastroenterology. In his new role, Dr. Routes will represent Children’s Hospital of Wisconsin on the CTSI executive committee.

Dr. Routes also is Professor of Medicine and Microbiology and Molecular Genetics, Section Chief of Allergy and Immunology at The Medical College of Wisconsin, and Medical Director of Allergy/Immunology at Children’s Hospital of Wisconsin. He conducts his research in the Children’s Research Institute.

Dr. Routes’ clinical interests include evaluation and treatment of primary immunodeficiencies with a special interest in pulmonary complications associated with primary immunodeficiency.  His specific areas of translational research include the use of adenovirus E1A as a adjuvant to induce antigen-specific anti-tumor immunity, to define the cause and optimize the treatment of the lymphoproliferative disorders and diffuse interstitial lung disease that occur with primary immunodeficiencies and to devise novel assays for conventional newborn screening protocols to diagnose infants with primary immunodeficiencies.  Dr. Routes was the principal investigator responsible for initiating the first statewide newborn screening program for severe combined immunodeficiency (SCID) in the United States.

Dr. Routes received his MD from the Indiana University School of Medicine in Indianapolis. He completed his residency in Internal Medicine at the University of Utah Medical Center in Salt Lake City and a fellowship in Allergy and Clinical Immunology at National Jewish Health and University of Colorado Health Sciences center in Denver. Dr. Routes is a member of the NIH study section “Investigations in Primary Immunodeficiency”, is president-elect of the Clinical Immunology Society and was recognized by U.S News and World Reports as a Top Doctor.

Carlos De La Peña
carlos1@uw.edu


NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

Zablocki VA Medical CenterMedical College of WisconsinMSOE